Anavex Life Sciences (AVXL) Shares Outstanding (Entity) (2012 - 2026)
Anavex Life Sciences (AVXL) recorded Shares Outstanding (Entity) of 92.7 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 8.5% from 85.41 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Anavex Life Sciences (AVXL) Shares Outstanding (Entity) (2012 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Anavex Life Sciences reported Shares Outstanding (Entity) of 86.67 million, up 2.2% from FY2024.
- Annual Shares Outstanding (Entity) has increased for 12 straight fiscal years, with a five-year compound annual growth rate of 6.9% (FY2020 to FY2025).
- Across earlier fiscal years, Shares Outstanding (Entity) came in at 84.8 million in FY2024 (+3.3%), 82.07 million in FY2023 (+5.3%), 77.94 million in FY2022 (+2.7%) and 75.92 million in FY2021 (+22.4%).
- On a year-over-year basis, Shares Outstanding (Entity) has increased for 51 consecutive quarters, with growth averaging 4.8% over the last eight quarters.
- Over the past five years, the year-over-year growth in Shares Outstanding (Entity) ranged from 0.7% (fiscal Q3 2025) to 22.4% (fiscal Q4 2021).
- Per Business Quant, the preceding three fiscal quarters came in at 92.7 million (Q2 2026), 92.67 million (Q1 2026) and 86.67 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | Anavex Life Sciences | 187.25 Mn | -292.83 Mn | - | 92.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 92.70 Mn |
| Mar 31, 2026 | 92.70 Mn |
| Dec 31, 2025 | 92.67 Mn |
| Sep 30, 2025 | 86.67 Mn |
| Jun 30, 2025 | 85.41 Mn |
| Mar 31, 2025 | 85.33 Mn |
| Dec 31, 2024 | 84.99 Mn |
| Sep 30, 2024 | 84.80 Mn |
| Jun 30, 2024 | 84.80 Mn |
| Mar 31, 2024 | 83.62 Mn |
| Dec 31, 2023 | 82.09 Mn |
| Sep 30, 2023 | 82.07 Mn |
| Jun 30, 2023 | 81.39 Mn |
| Mar 31, 2023 | 80.24 Mn |
| Dec 31, 2022 | 78.03 Mn |
| Sep 30, 2022 | 77.94 Mn |
| Jun 30, 2022 | 77.94 Mn |
| Mar 31, 2022 | 77.16 Mn |
| Dec 31, 2021 | 76.16 Mn |
| Sep 30, 2021 | 75.92 Mn |
API Access
Anavex Life Sciences Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=AVXL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "AVXL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=AVXL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();